AI/ML Innovations Inc

AI/ML Innovations — Investor Presentation (February 2024)

24 slides from AI/ML Innovations's investor presentation, Feb 14, 2024

  1. Slide 1: Revolutionizing Healthcare: The Future of Wearables, AI, and Remote Patient Monitoring

    Slide 1: Revolutionizing Healthcare: The Future of Wearables, AI, and Remote Patient Monitoring

    CSE: AIML OTCQB: AIMLF FWB: 42FB Health Paul Duffy || CEO Intelligence Revolutionizing Healthcare: The Future of Wearables, AI, and Remote Patient Monitoring Enabling Healthier Futures February 14th, 2024

  2. Slide 2: Forward Looking Statement

    Slide 2: Forward Looking Statement

    Forward Looking Statement This presentation may contain forward-looking statements that involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of AI/ML Innovations Inc., or industry results to be materially different from an

  3. Slide 3: Town Hall Agenda

    Slide 3: Town Hall Agenda

    Enabling Healthier Futures TOWN HALL AGENDA ● What we Do ● The Next 90 Days ● Milestones & Updates ● Questions & Answers

  4. Slide 4: The AI/ML Biometric Journey

    Slide 4: The AI/ML Biometric Journey

    The AI/ML Biometric Journey Capture Smart Sensor Wearables Capture biometric signals or pulses through our “Pulse Whisperer” API’s, Connectors, SDK For Time-Series Data Collection Analyze Analyze using our proprietary and patented Neural Networks, Machine Learning, and Artificial Intelligence servic

  5. Slide 5: Non-invasive AI/ML Blood Pressure

    Slide 5: Non-invasive AI/ML Blood Pressure

    2023 Innovation Grand Prize at the prestigious L'Encéphale Medical Congress in Paris Non-invasive AI/ML Blood Pressure

  6. Slide 6: The First 100 Days: Milestones Q4, CY 2023

    Slide 6: The First 100 Days: Milestones Q4, CY 2023

    The First 100 Days: Milestones Q4, CY 2023 One: Book $1.0MM in orders for 2024 ● Health Gauge Inc. (95.2% owned by AIML) ○ In North America, renews approximately $300K CDN ○ Professional Services & License Agreement of the Health Gauge Platform and Neural Net ● Tech2Heal (up to 22% ownership rights,

  7. Slide 7: Sales are Starting

    Slide 7: Sales are Starting

    Sales are Starting From Pitch to Purchase Traction in the First 100 Days: ● AI and Remote Patient Monitoring for Blood Pressure Management ● AI Licensing for Patented Neural Net ● Clinical Trial Management Systems ● University Hospital of Nice Aging Well Clinical Study - 2 Trials Underway ● Europe’s

  8. Slide 8: Aging Well

    Slide 8: Aging Well

    Aging Well CLINICAL TRIAL HIGHLIGHTS Personalized program for preventing loss of autonomy in the elderly: Key Metrics - Accessibility, Empowerment, and Environmental Adaptations The CHU is launching the biggest decentralized clinical trial in order to prevent loss of autonomy in the elderly. With a

  9. Slide 9: My Health Friend

    Slide 9: My Health Friend

    My Health Friend Funded by a European Commission Fund ● Multi-language Health App for Cross-Border Populations (French, Italian, English) - Personalized Digital Rehabilitation to Prevent Chronic Diseases, Reduce Socio-Health Impact. Objective 1 - Setup and Data Collection ● Target Study: General pop

  10. Slide 10: Prescription for Growth: Investing in the Clinical Trials Boom

    Slide 10: Prescription for Growth: Investing in the Clinical Trials Boom

    Prescription for Growth: Investing in the Clinical Trials Boom The global clinical trial management system market size was estimated at USD 1.6 billion in 2022 and it is expected to reach around USD 5.22 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 12.6% during the fore

  11. Slide 11: The Next 90 Days: Milestones Q1, CY 2024

    Slide 11: The Next 90 Days: Milestones Q1, CY 2024

    The Next 90 Days: Milestones Q1, CY 2024 One: Build Funnel, Create Pipeline ● Jan 15th - Launch of the Health Gauge Biometrics website ○ Aligned to Product / Market Fit with SEO/SEM for Lead Gen ● Secure Pilot Programs and New Accounts Two: Build Products ● Jan 31st - Launch of v1.0 of The Pulse Whi

  12. Slide 12: Biometrics Unleashed: Welcome to Health Tech 2.0

    Slide 12: Biometrics Unleashed: Welcome to Health Tech 2.0

    & Biometrics Unleashed Welcome to Health Tech 2.0 The Era of Health Intelligence At the dawn of 2024, advancements in Artificial Intelligence (Al). Predictive Analytics (PA), Large Language Models (LLM) and Transformers (GPT) have reset everything to a new normal. Scroll to Dream ¢ HealthGauge Home

  13. Slide 13: The Pulse Whisperer v1.0 Launch

    Slide 13: The Pulse Whisperer v1.0 Launch

    es eX HealthGauge Home Products v Solutions Learn About Us { Support Monday 7h 40m oy = V1.0 LAUNCHING JANUARY 31, 2024 Need Biometric Raw Signal Data?

  14. Slide 14: Follow Your Heart v1.0 Launch

    Slide 14: Follow Your Heart v1.0 Launch

    <> eS HealthGauge Home Products Solutions Learn = About Us Moen Support ® °.@ e A ay ry V1.0 LAUNCHING FEBRUARY 29, 2024 Follow Your Heart Non Invasive Blood Pressure Measuremerit & Monitoring 7 Edit site

  15. Slide 15: Care pathway platform screenshot

    Slide 15: Care pathway platform screenshot

    o* *#O@: Cardiac cS 109/73 36 a 2 ® HealthCare Solutions, Inc > Healthcare Worker | Dr. Ryan Mitchell s) BP HRV (RMSSD) h ECG v A Se Setup 7 | 83 122/75 22 = HR (bpm) BP (mmhg) HRV & Survey &% Groups PPG vA & Rules 30k 5 Calendar Care People hat wach ECG Peaks Ee meet.google.com is sharing your scre

  16. Slide 16: Non-Invasive Blood Pressure Product

    Slide 16: Non-Invasive Blood Pressure Product

    Non-Invasive Blood Pressure Product Unit Price $249.99 Heart Disease Impact Fact - Blood pressure measurement is a key diagnostic and preventive 100 MILLION tool in the context of heart disease PEOPLE AFFECTED IN NORTH AMERICA 1.5 BILLION Percentage Units Revenue PEOPLE AFFECTED WORLDWIDE 0.05% 50,0

  17. Slide 17: Neural Nets: Training & FDA

    Slide 17: Neural Nets: Training & FDA

    Neural Nets: Training & FDA Why are we doing all this? ● Biometric Smart Sensors need Neural Nets to convert Signals & Pulses to precise measurements. ○ Transforming millions of inputs into actionable insights through our innovative biometric InfoPulse. (more on this in our Next 100 Days) ● Advance

  18. Slide 18: mmHG - Millimeters of Mercury

    Slide 18: mmHG - Millimeters of Mercury

    * mmHG - Millimeters of Mercury

  19. Slide 19: mmHG - Millimeters of Mercury

    Slide 19: mmHG - Millimeters of Mercury

    * mmHG - Millimeters of Mercury

  20. Slide 20: Health Gauge Regulatory: Current NN Solution Version 1.0

    Slide 20: Health Gauge Regulatory: Current NN Solution Version 1.0

    HEALTH GAUGE REGULATORY: Current NN Solution: Version 1.0 Model _... as of February 12, 2024 HG SYSTOLIC Blood Pressure DIASTOLIC Blood Pressure ara SYS (ST-Dev) MEAN AVG DIA (ST-Dev) | _ MEAN AVG Note: The ST-DEV numbers and MAD mmHg Deviation (MAD) mmHg Deviation (MAD) numbers are getting lower. D

  21. Slide 21: 132/78

    Slide 21: 132/78

    132/78

  22. Slide 22: Health Gauge Biometrics Platform for Life Sciences

    Slide 22: Health Gauge Biometrics Platform for Life Sciences

    Health Gauge Biometrics Platform for Life Sciences Unleash your Quantified Self Improve your health through an incremental and data- informed approach. Learn more le gat BloodPressure —g4syS_S6DIA Weedy verege Heart rate Todey Week Month Year 180 40 Daily Lowest Resting HR 122.SyS Welty average

  23. Slide 23: Health Gauge V2.0 Launching March 31, 2024

    Slide 23: Health Gauge V2.0 Launching March 31, 2024

    8B HealthGauge ae V2.0 LAUNCHING MARCH 31, 2024 Biometric Magic Prioritize Your Well-being: Where Continuous Monitoring, Precision, Privacy, and Hedith take Center Stage Support

  24. Slide 24: Questions & Answers

    Slide 24: Questions & Answers

    Questions & Answers Revolutionizing Healthcare: The Future of Wearables, AI, and Remote Patient Monitoring Enabling Healthier Futures

Source: Internet Archive copy of aiml-innovations.com

More decks from AI/ML Innovations Inc